Katsumichi Fujimaki - Concepedia

Author

Katsumichi Fujimaki

Also Known As

Hideyuki Koharazawa, K Fujimaki, K. FUJIMAKI, K. Fujimaki, Katsumichi Fujimaki, Kota Fujimaki, Kotaro FUJIMAKI, Maho Ishikawa, Takaaki Ono

168

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Yokohama City University Fujisawa City Hospital Yokohama City University Medical Center Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

About

Katsumichi Fujimaki is an author at Yokohama City University specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	31	1.1K
2	Health Sciences	8	8	274
3	Natural Sciences	2	2	105
4	Public Health	1	1	14
5	Allergy	1	1	41

Katsumichi Fujimaki

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group Fumihiko Hayakawa, Toru Sakura, Toshiaki Yujiri, Blood Cancer Journal Hematological MalignancyYoung AdultsOncologyAdolescent MedicinePediatric Epidemiology	2014	104
Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: Relationship with type of latent Epstein‐Barr virus infection Takuya Miyazaki, Katsumichi Fujimaki, Yukari Shirasugi, American Journal of Hematology	2007	98
Affixin interacts with α-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell–substrate interaction Satoshi Yamaji, Atsushi Suzuki, Heiwa Kanamori, The Journal of Cell Biology Initial Cell–substrate InteractionCell AdhesionMolecular BiologyCytoskeletonCellular Physiology	2004	81
Immune reconstitution assessed during five years after allogeneic bone marrow transplantation Katsumichi Fujimaki, A Maruta, Minoru Yoshida, Bone Marrow Transplantation TransplantationMarrow TransplantationAutoimmune DiseaseBone Marrow FailureMedicine	2001	80
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia Masamitsu Yanada, Motohiro Tsuzuki, Hiroyuki Fujita, Blood	2013	78
Central Nervous System Relapse of Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Kumi Oshima, Yoshinobu Kanda, Takuya Yamashita, Biology of Blood and Marrow Transplantation Cell TherapyMixed-phenotype Acute LeukemiaCell Replacement TherapyCns RelapseMyeloid Neoplasia	2008	73
A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, Haematologica	2017	60
Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation Chiaki Nakaseko, Shinichi Ozawa, Emiko Sakaida, International Journal of Hematology Lung TransplantationTransplantationMarrow TransplantationBronchiolitis ObliteransGraft Survival	2011	59
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era Reina Watanabe, Naoto Tomita, Megumi Itabashi, European Journal Of Haematology	2013	57
Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients Katsumichi Fujimaki, Takehiko Mori, Aiko Kida, International Journal of Hematology TransplantationViral PersistenceStem Cell TransplantationImmunologyHematology	2006	52

Page 1